These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19307154)

  • 21. Restless Legs Syndrome Shows Increased Silent Postmortem Cerebral Microvascular Disease With Gliosis.
    Walters AS; Paueksakon P; Adler CH; Moussouttas M; Weinstock LB; Spruyt K; Bagai K
    J Am Heart Assoc; 2021 Jun; 10(11):e019627. PubMed ID: 33998250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alterations of Dopamine-Related Transcripts in A11 Diencephalospinal Pathways after Spinal Cord Injury.
    Zhao S; DeFinis JH; Hou S
    Neural Plast; 2021; 2021():8838932. PubMed ID: 33510781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical correlates of 6-hydroxydopamine injections into A11 dopaminergic neurons in rats: a possible model for restless legs syndrome.
    Ondo WG; He Y; Rajasekaran S; Le WD
    Mov Disord; 2000 Jan; 15(1):154-8. PubMed ID: 10634257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperdopaminergism in lenticulostriate stroke-related restless legs syndrome: an imaging study.
    Ruppert E; Bataillard M; Namer IJ; Tatu L; Hacquard A; Hugueny L; Hubbard J; Kilic-Huck U; Wolff V; Bourgin P
    Sleep Med; 2017 Feb; 30():136-138. PubMed ID: 28215236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ibotenic acid-induced lesions of striatal target and projection neurons: ultrastructural manifestations in dopaminergic and non-dopaminergic neurons and in glia.
    Smith DE; Saji M; Joh TH; Reis DJ; Pickel VM
    Histol Histopathol; 1987 Jul; 2(3):251-63. PubMed ID: 2908792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered brain iron homeostasis and dopaminergic function in Restless Legs Syndrome (Willis-Ekbom Disease).
    Earley CJ; Connor J; Garcia-Borreguero D; Jenner P; Winkelman J; Zee PC; Allen R
    Sleep Med; 2014 Nov; 15(11):1288-301. PubMed ID: 25201131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies.
    Turjanski N; Lees AJ; Brooks DJ
    Neurology; 1999 Mar; 52(5):932-7. PubMed ID: 10102408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine cell morphology and glial cell hypertrophy and process branching in the nigrostriatal system after striatal 6-OHDA analyzed by specific sterological tools.
    Gomide V; Bibancos T; Chadi G
    Int J Neurosci; 2005 Apr; 115(4):557-82. PubMed ID: 15804725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteopontin expression in activated glial cells following mechanical- or toxin-induced nigral dopaminergic cell loss.
    Iczkiewicz J; Rose S; Jenner P
    Exp Neurol; 2007 Sep; 207(1):95-106. PubMed ID: 17643430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postmortem and imaging based analyses reveal CNS decreased myelination in restless legs syndrome.
    Connor JR; Ponnuru P; Lee BY; Podskalny GD; Alam S; Allen RP; Earley CJ; Yang QX
    Sleep Med; 2011 Jun; 12(6):614-9. PubMed ID: 21570342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased striatal dopamine transporter density in moderately severe old restless legs syndrome patients.
    Kim KW; Jhoo JH; Lee SB; Lee SD; Kim TH; Kim SE; Kim YK; Yoon IY
    Eur J Neurol; 2012 Sep; 19(9):1213-8. PubMed ID: 22435397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pathophysiology of restless legs syndrome].
    Monaca C
    Presse Med; 2010 May; 39(5):587-91. PubMed ID: 20346613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Guidance of dopaminergic neuritic growth by immature astrocytes in organotypic cultures of rat fetal ventral mesencephalon.
    Johansson S; Strömberg I
    J Comp Neurol; 2002 Feb; 443(3):237-49. PubMed ID: 11807834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. On the pathway of an animal model for restless legs syndrome..
    Manconi M; Hutchins W; Feroah TR; Zucconi M; Ferini-Strambi L
    Neurol Sci; 2007 Jan; 28 Suppl 1():S53-60. PubMed ID: 17235432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does the endogenous opiate system play a role in the Restless Legs Syndrome? A pilot post-mortem study.
    Walters AS; Ondo WG; Zhu W; Le W
    J Neurol Sci; 2009 Apr; 279(1-2):62-5. PubMed ID: 19167016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diagnosis and novel treatment approaches in restless legs syndrome: I. Pathophysiology and diagnosis].
    Hirata K; Suzuki K
    Brain Nerve; 2013 Oct; 65(10):1185-97. PubMed ID: 24101430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emergence of restless legs syndrome after subthalamic stimulation in Parkinson's disease: a dopaminergic overstimulation?
    Marques A; Fantini ML; Morand D; Pereira B; Derost P; Ulla M; Debilly B; Lemaire JJ; Durif F
    Sleep Med; 2015 May; 16(5):583-8. PubMed ID: 25881920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormally increased CSF 3-Ortho-methyldopa (3-OMD) in untreated restless legs syndrome (RLS) patients indicates more severe disease and possibly abnormally increased dopamine synthesis.
    Allen RP; Connor JR; Hyland K; Earley CJ
    Sleep Med; 2009 Jan; 10(1):123-8. PubMed ID: 18226951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperactivity, dopaminergic abnormalities, iron deficiency and anemia in an in vivo opioid receptors knockout mouse: Implications for the restless legs syndrome.
    Lyu S; DeAndrade MP; Mueller S; Oksche A; Walters AS; Li Y
    Behav Brain Res; 2019 Nov; 374():112123. PubMed ID: 31376441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The acute and the long-term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial cell activation.
    Iravani MM; Leung CC; Sadeghian M; Haddon CO; Rose S; Jenner P
    Eur J Neurosci; 2005 Jul; 22(2):317-30. PubMed ID: 16045485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.